Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President)
will be in Chicago at the ASCO (American Society of Clinical Oncology) annual meeting, May 31 – June 3, 2024, taking place at the McCormick Place convention center.

They are thrilled to engage with clinical experts worldwide, explore cutting-edge research, and discover innovative treatments.